Combined bronchodilators (tiotropium plus olodaterol) for patients with chronic obstructive pulmonary disease
Chronic obstructive pulmonary disease (COPD), a respiratory disease characterized by a progressive decline in lung function, is considered to be a leading cause of morbidity and mortality. Long-acting inhaled bronchodilators, such as long-acting β2 agonists (LABAs) or long-acting muscarinic antagoni...
Saved in:
| Main Author: | Ramadan, Wijdan H. (author) |
|---|---|
| Other Authors: | Kabbara, Wissam K. (author), El Khoury, Ghada (author), Al Assir, Sarah A. (author) |
| Format: | article |
| Published: |
2015
|
| Online Access: | http://hdl.handle.net/10725/4446 http://dx.doi.org/10.2147/COPD.S88246 http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4634833/ |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Olodaterol for the treatment of chronic obstructive pulmonary disease
by: Ramadan, Wijdan H.
Published: (2016) -
Patterns of use of dry powder inhalers versus pressurized metered-dose inhalers devices in adult patients with chronic obstructive pulmonary disease or asthma:
by: Ramadan, Wijdan H.
Published: (2017) -
Multi-ancestry genome-wide association analyses improve resolution of genes and pathways influencing lung function and chronic obstructive pulmonary disease risk
by: Nick Shrine (220391)
Published: (2023) -
Efficacy and safety of ensifentrine, a novel phosphodiesterase 3 and 4 inhibitor, in chronic obstructive pulmonary disease: A systematic review and meta-analysis
by: Eeshal Fatima (18255772)
Published: (2024) -
Author Correction: Multi-ancestry genome-wide association analyses improve resolution of genes and pathways influencing lung function and chronic obstructive pulmonary disease risk
by: Nick Shrine (220391)
Published: (2023)